44 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
candidate can unexpectedly fail at any stage of preclinical and clinical development. Our investments in our early-stage research and development … efforts may not yield any promising product candidates. Even if our research and development efforts yield product candidates that advance into clinical
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
with our existing cash and cash equivalents, (i) to continue research and development relating to our clinical, preclinical and discovery-stage programs … in our early-stage research and development efforts may not yield any promising product candidates. Even if our research and development efforts yield
8-K
EX-99.1
ZYME
Zymeworks Inc.
2 May 24
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:07pm
.
Progression of Research & Development Programs
Presentation of five posters at the AACR Annual Meeting in April. Posters included two presentations from our … was also appointed to serve as a member of the research and development committee of the board of directors. Dr. Gallagher is the sixth new director
8-K
ZYME
Zymeworks Inc.
28 Mar 24
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
4:16pm
agreement for directors and executive officers.
Dr. Gallagher will be appointed as a member of the research and development committee of the Board, effective … herein by reference.
Item 8.01
Other Events.
Following Dr. Gallagher’s appointment to the Board’s research and development committee, the composition
8-K
EX-99.1
ym0mbu1csc8xkv
28 Mar 24
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
4:16pm
8-K
EX-99.1
g3y7msbpzdcf qyfr4n
6 Mar 24
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
4:13pm
8-K
d695ivem6h27y
8 Feb 24
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
4:16pm
8-K
EX-99.1
kkb2uioxt mlzj5a
8 Feb 24
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
4:16pm
8-K
EX-10.1
tv9ryzyi
26 Dec 23
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
8:09am
8-K
EX-99.1
s7bdmls3ckrgwqc6y kn
26 Dec 23
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
8:09am
8-K
4ylvzxxwhp7u giwf
8 Dec 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
EX-99.1
a0ltrhivp0q3luswio3
7 Nov 23
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
8-K
fsmf1sh885qpb2zt3ebg
2 Nov 23
Termination of a Material Definitive Agreement
4:17pm